Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pisiform Bone | 1 | 2021 | 1 | 0.750 |
Why?
|
Wrist Injuries | 1 | 2021 | 215 | 0.610 |
Why?
|
Interleukins | 3 | 2015 | 792 | 0.580 |
Why?
|
Receptors, Cell Surface | 4 | 2011 | 2819 | 0.580 |
Why?
|
Sleep Apnea, Obstructive | 4 | 2009 | 1890 | 0.470 |
Why?
|
Myocytes, Cardiac | 5 | 2012 | 1683 | 0.440 |
Why?
|
Accidental Falls | 1 | 2021 | 1081 | 0.410 |
Why?
|
Narcolepsy | 3 | 2019 | 200 | 0.400 |
Why?
|
Paracrine Communication | 2 | 2012 | 278 | 0.390 |
Why?
|
Fractures, Comminuted | 1 | 2011 | 57 | 0.370 |
Why?
|
Arthroplasty, Replacement, Ankle | 1 | 2011 | 26 | 0.370 |
Why?
|
Heart Failure | 10 | 2020 | 11857 | 0.360 |
Why?
|
Interleukin-6 | 5 | 2022 | 3234 | 0.360 |
Why?
|
Adrenomedullin | 1 | 2009 | 85 | 0.330 |
Why?
|
Joint Prosthesis | 1 | 2011 | 251 | 0.330 |
Why?
|
Radius Fractures | 2 | 2013 | 514 | 0.320 |
Why?
|
Receptors, Interleukin-1 | 1 | 2009 | 262 | 0.310 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2010 | 344 | 0.310 |
Why?
|
Compartment Syndromes | 1 | 2010 | 159 | 0.310 |
Why?
|
Weight-Bearing | 1 | 2011 | 533 | 0.300 |
Why?
|
Casts, Surgical | 3 | 2021 | 184 | 0.280 |
Why?
|
Ankle Joint | 1 | 2011 | 447 | 0.280 |
Why?
|
Coronary Vasospasm | 2 | 2007 | 81 | 0.270 |
Why?
|
Femoral Fractures | 2 | 2013 | 376 | 0.270 |
Why?
|
Troponin T | 1 | 2011 | 787 | 0.260 |
Why?
|
Potassium Channels, Inwardly Rectifying | 2 | 2007 | 144 | 0.260 |
Why?
|
Receptors, Neurokinin-3 | 2 | 2016 | 59 | 0.260 |
Why?
|
ATP-Binding Cassette Transporters | 2 | 2007 | 568 | 0.260 |
Why?
|
Aminoquinolines | 2 | 2016 | 105 | 0.260 |
Why?
|
Stress, Physiological | 2 | 2012 | 1409 | 0.240 |
Why?
|
Fractures, Closed | 1 | 2005 | 88 | 0.230 |
Why?
|
Adenosine Triphosphate | 2 | 2012 | 2003 | 0.230 |
Why?
|
Bone Nails | 1 | 2005 | 220 | 0.220 |
Why?
|
Disorders of Excessive Somnolence | 1 | 2007 | 277 | 0.220 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2011 | 1751 | 0.220 |
Why?
|
Renal Insufficiency, Chronic | 3 | 2022 | 2291 | 0.210 |
Why?
|
Myocardial Reperfusion Injury | 2 | 2011 | 484 | 0.210 |
Why?
|
Fracture Fixation, Intramedullary | 1 | 2005 | 160 | 0.210 |
Why?
|
Positive-Pressure Respiration | 1 | 2007 | 713 | 0.210 |
Why?
|
Sulfonamides | 3 | 2017 | 1988 | 0.200 |
Why?
|
Myocardium | 6 | 2017 | 4788 | 0.200 |
Why?
|
Heart-Assist Devices | 2 | 2010 | 1292 | 0.200 |
Why?
|
Perioperative Care | 2 | 2019 | 1046 | 0.180 |
Why?
|
Apolipoprotein C-II | 1 | 2020 | 15 | 0.180 |
Why?
|
Polysomnography | 1 | 2007 | 1864 | 0.180 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2001 | 239 | 0.170 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2006 | 1494 | 0.160 |
Why?
|
Fibroblasts | 1 | 2010 | 4180 | 0.160 |
Why?
|
Inflammation | 5 | 2020 | 10865 | 0.160 |
Why?
|
Anti-Inflammatory Agents | 2 | 2020 | 1816 | 0.160 |
Why?
|
Hemorrhage | 2 | 2010 | 3458 | 0.160 |
Why?
|
Sleep Apnea Syndromes | 1 | 2007 | 981 | 0.160 |
Why?
|
Peptide Fragments | 1 | 2011 | 5152 | 0.150 |
Why?
|
Apolipoprotein C-III | 1 | 2020 | 210 | 0.150 |
Why?
|
Heart Ventricles | 2 | 2022 | 3839 | 0.150 |
Why?
|
Receptors, Interleukin-8B | 1 | 2017 | 58 | 0.150 |
Why?
|
Anesthesia | 2 | 2019 | 1596 | 0.140 |
Why?
|
Serine Endopeptidases | 1 | 2022 | 1032 | 0.140 |
Why?
|
Drug Delivery Systems | 1 | 2008 | 2238 | 0.140 |
Why?
|
Snoring | 2 | 2009 | 209 | 0.130 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2018 | 425 | 0.130 |
Why?
|
Acute Kidney Injury | 1 | 2008 | 1943 | 0.130 |
Why?
|
Testosterone | 2 | 2016 | 2493 | 0.120 |
Why?
|
Conscious Sedation | 1 | 2019 | 535 | 0.120 |
Why?
|
Anticoagulants | 1 | 2010 | 4840 | 0.120 |
Why?
|
Contrast Media | 1 | 2008 | 5336 | 0.120 |
Why?
|
Cardiomegaly | 2 | 2015 | 591 | 0.110 |
Why?
|
Hospital Mortality | 1 | 2008 | 5371 | 0.110 |
Why?
|
Luteinizing Hormone | 1 | 2016 | 821 | 0.110 |
Why?
|
Spondylolisthesis | 1 | 2015 | 173 | 0.110 |
Why?
|
Nitric Oxide Synthase | 3 | 2005 | 911 | 0.110 |
Why?
|
Giant Cell Tumor of Bone | 1 | 2013 | 119 | 0.100 |
Why?
|
Triglycerides | 1 | 2020 | 2465 | 0.100 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2016 | 383 | 0.100 |
Why?
|
Fractures, Spontaneous | 1 | 2013 | 232 | 0.100 |
Why?
|
Humans | 41 | 2022 | 768451 | 0.100 |
Why?
|
Nuclear Pore | 1 | 2012 | 62 | 0.090 |
Why?
|
Renal Dialysis | 1 | 2020 | 1802 | 0.090 |
Why?
|
Anemia | 1 | 2020 | 1521 | 0.090 |
Why?
|
Ventricular Function, Left | 2 | 2019 | 3941 | 0.090 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 2279 | 0.090 |
Why?
|
Cardiovascular Diseases | 5 | 2022 | 15638 | 0.090 |
Why?
|
NIH 3T3 Cells | 1 | 2012 | 669 | 0.090 |
Why?
|
Asthma | 1 | 2009 | 6274 | 0.090 |
Why?
|
Anterior Cruciate Ligament | 1 | 2013 | 423 | 0.090 |
Why?
|
Male | 23 | 2021 | 364781 | 0.080 |
Why?
|
Receptors, Drug | 2 | 2007 | 157 | 0.080 |
Why?
|
Chemokine CXCL12 | 1 | 2011 | 457 | 0.080 |
Why?
|
Anesthesiology | 1 | 2019 | 1137 | 0.080 |
Why?
|
Ligaments, Articular | 1 | 2011 | 304 | 0.080 |
Why?
|
Kidney Failure, Chronic | 1 | 2020 | 2489 | 0.070 |
Why?
|
Stroke Volume | 2 | 2019 | 5620 | 0.070 |
Why?
|
Peptides | 1 | 2020 | 4368 | 0.070 |
Why?
|
Uvula | 1 | 2007 | 15 | 0.070 |
Why?
|
Cheyne-Stokes Respiration | 1 | 2007 | 38 | 0.070 |
Why?
|
Cytoplasm | 1 | 2012 | 1503 | 0.070 |
Why?
|
Disease Management | 1 | 2018 | 2533 | 0.070 |
Why?
|
Palate, Soft | 1 | 2007 | 100 | 0.070 |
Why?
|
Treatment Outcome | 6 | 2021 | 65409 | 0.070 |
Why?
|
Gene Transfer Techniques | 1 | 2012 | 1209 | 0.070 |
Why?
|
Stress, Mechanical | 1 | 2012 | 1680 | 0.070 |
Why?
|
Coronary Vessels | 1 | 2017 | 3122 | 0.060 |
Why?
|
Dystrophin | 2 | 2004 | 284 | 0.060 |
Why?
|
Fracture Fixation, Internal | 1 | 2013 | 981 | 0.060 |
Why?
|
Microtubules | 1 | 2012 | 1074 | 0.060 |
Why?
|
Lumbar Vertebrae | 1 | 2015 | 1885 | 0.060 |
Why?
|
Administration, Inhalation | 1 | 2009 | 1170 | 0.060 |
Why?
|
Spinal Fusion | 1 | 2015 | 1310 | 0.060 |
Why?
|
Apoptosis | 2 | 2005 | 9526 | 0.060 |
Why?
|
Animals | 15 | 2020 | 169418 | 0.060 |
Why?
|
Kidney Function Tests | 1 | 2008 | 681 | 0.060 |
Why?
|
Injections, Intravenous | 1 | 2008 | 1379 | 0.060 |
Why?
|
Membrane Proteins | 1 | 2022 | 7895 | 0.060 |
Why?
|
Middle Aged | 13 | 2021 | 223418 | 0.060 |
Why?
|
Pulmonary Ventilation | 1 | 2007 | 377 | 0.060 |
Why?
|
Signal Transduction | 1 | 2008 | 23638 | 0.060 |
Why?
|
Bacillus anthracis | 1 | 2005 | 120 | 0.060 |
Why?
|
Pyrimidines | 1 | 2017 | 3050 | 0.060 |
Why?
|
Electrodes | 1 | 2007 | 618 | 0.060 |
Why?
|
Pulmonary Embolism | 1 | 2018 | 2591 | 0.060 |
Why?
|
Masks | 1 | 2007 | 215 | 0.060 |
Why?
|
Glomerular Filtration Rate | 2 | 2017 | 2226 | 0.060 |
Why?
|
Neutrophils | 1 | 2017 | 3790 | 0.060 |
Why?
|
Sarcolemma | 1 | 2004 | 66 | 0.060 |
Why?
|
Pharynx | 1 | 2007 | 436 | 0.060 |
Why?
|
Receptor, Angiotensin, Type 1 | 1 | 2005 | 153 | 0.060 |
Why?
|
Leukemia | 1 | 1992 | 1527 | 0.060 |
Why?
|
Range of Motion, Articular | 1 | 2011 | 1599 | 0.060 |
Why?
|
Drug Therapy | 1 | 2007 | 504 | 0.060 |
Why?
|
Prosthesis Design | 1 | 2011 | 2126 | 0.060 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 1 | 2007 | 326 | 0.060 |
Why?
|
Biomedical Research | 1 | 2019 | 3463 | 0.050 |
Why?
|
Kidney | 2 | 2017 | 7064 | 0.050 |
Why?
|
Double-Blind Method | 4 | 2020 | 12450 | 0.050 |
Why?
|
Radiography | 3 | 2015 | 6995 | 0.050 |
Why?
|
Sleep | 1 | 2019 | 4796 | 0.050 |
Why?
|
Sleep Stages | 1 | 2007 | 702 | 0.050 |
Why?
|
Cell Nucleus | 1 | 2012 | 2889 | 0.050 |
Why?
|
Video Recording | 1 | 2007 | 974 | 0.050 |
Why?
|
Continuous Positive Airway Pressure | 1 | 2007 | 578 | 0.050 |
Why?
|
Nervous System Diseases | 1 | 1992 | 1668 | 0.050 |
Why?
|
Extracellular Matrix | 1 | 2010 | 1738 | 0.050 |
Why?
|
Cytoskeletal Proteins | 2 | 2004 | 1337 | 0.050 |
Why?
|
Gastroesophageal Reflux | 1 | 2009 | 833 | 0.050 |
Why?
|
Bone Neoplasms | 1 | 2013 | 2562 | 0.050 |
Why?
|
Female | 17 | 2020 | 396943 | 0.050 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2008 | 1724 | 0.050 |
Why?
|
Severity of Illness Index | 3 | 2008 | 15965 | 0.050 |
Why?
|
Models, Biological | 2 | 2016 | 9505 | 0.040 |
Why?
|
Primary Prevention | 1 | 2008 | 1189 | 0.040 |
Why?
|
Calpain | 1 | 2001 | 147 | 0.040 |
Why?
|
Antigens, Bacterial | 1 | 2005 | 1150 | 0.040 |
Why?
|
Reference Values | 1 | 2007 | 4941 | 0.040 |
Why?
|
Bacterial Toxins | 1 | 2005 | 926 | 0.040 |
Why?
|
Heart | 2 | 2011 | 4451 | 0.040 |
Why?
|
Survival Rate | 2 | 2019 | 12875 | 0.040 |
Why?
|
Adult | 14 | 2020 | 223542 | 0.040 |
Why?
|
Cause of Death | 2 | 2022 | 3727 | 0.040 |
Why?
|
Albumins | 1 | 2022 | 578 | 0.040 |
Why?
|
Glucocorticoids | 1 | 2009 | 2170 | 0.040 |
Why?
|
Lipoprotein Lipase | 1 | 2020 | 133 | 0.040 |
Why?
|
Mice | 8 | 2015 | 82045 | 0.040 |
Why?
|
Recurrence | 1 | 2011 | 8510 | 0.040 |
Why?
|
Half-Life | 1 | 2020 | 650 | 0.040 |
Why?
|
Acute Coronary Syndrome | 1 | 2011 | 2195 | 0.040 |
Why?
|
Lipolysis | 1 | 2020 | 211 | 0.040 |
Why?
|
Molecular Weight | 1 | 2001 | 2173 | 0.040 |
Why?
|
Mice, Inbred C57BL | 2 | 2020 | 22365 | 0.040 |
Why?
|
Pain | 1 | 2013 | 5096 | 0.040 |
Why?
|
Hematinics | 1 | 2020 | 282 | 0.040 |
Why?
|
Coronary Artery Disease | 1 | 2017 | 6551 | 0.040 |
Why?
|
Immunoenzyme Techniques | 1 | 2001 | 1706 | 0.040 |
Why?
|
Tyrphostins | 1 | 1997 | 63 | 0.040 |
Why?
|
Aged | 8 | 2020 | 171520 | 0.040 |
Why?
|
Blotting, Western | 2 | 2005 | 5042 | 0.040 |
Why?
|
London | 1 | 2017 | 233 | 0.040 |
Why?
|
Serum Albumin | 1 | 2020 | 676 | 0.040 |
Why?
|
Disease Progression | 2 | 2019 | 13655 | 0.040 |
Why?
|
Ventricular Remodeling | 1 | 2005 | 1280 | 0.040 |
Why?
|
Primates | 1 | 2020 | 523 | 0.040 |
Why?
|
Motor Activity | 1 | 2007 | 2722 | 0.040 |
Why?
|
Nitroprusside | 1 | 1997 | 272 | 0.040 |
Why?
|
Patient Compliance | 1 | 2007 | 2696 | 0.030 |
Why?
|
Electrocardiography | 2 | 2011 | 6410 | 0.030 |
Why?
|
Isometric Contraction | 1 | 1997 | 150 | 0.030 |
Why?
|
Hypertriglyceridemia | 1 | 2020 | 293 | 0.030 |
Why?
|
Molecular Dynamics Simulation | 1 | 2020 | 434 | 0.030 |
Why?
|
Odds Ratio | 1 | 2009 | 9687 | 0.030 |
Why?
|
Creatinine | 1 | 2022 | 1915 | 0.030 |
Why?
|
Phosphotyrosine | 1 | 1997 | 458 | 0.030 |
Why?
|
Membrane Glycoproteins | 2 | 2004 | 3713 | 0.030 |
Why?
|
Inpatients | 1 | 2008 | 2561 | 0.030 |
Why?
|
Prognosis | 3 | 2019 | 30028 | 0.030 |
Why?
|
Risk Assessment | 3 | 2019 | 24311 | 0.030 |
Why?
|
Hypertension | 1 | 2015 | 8611 | 0.030 |
Why?
|
Vitamin E | 1 | 1999 | 873 | 0.030 |
Why?
|
Lordosis | 1 | 2015 | 97 | 0.030 |
Why?
|
Comorbidity | 1 | 2009 | 10601 | 0.030 |
Why?
|
Receptors, Interleukin | 1 | 2015 | 242 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2010 | 10494 | 0.030 |
Why?
|
Ligands | 1 | 2020 | 3281 | 0.030 |
Why?
|
Interdisciplinary Communication | 1 | 2019 | 937 | 0.030 |
Why?
|
Mice, Transgenic | 1 | 2006 | 9558 | 0.030 |
Why?
|
Muscle, Smooth | 1 | 1997 | 930 | 0.030 |
Why?
|
Angiography | 1 | 2018 | 1598 | 0.030 |
Why?
|
Mice, Knockout | 4 | 2015 | 14480 | 0.030 |
Why?
|
Glycoproteins | 1 | 2001 | 2206 | 0.030 |
Why?
|
Nitric Oxide Synthase Type II | 2 | 2005 | 518 | 0.030 |
Why?
|
Tyrosine | 1 | 1997 | 1428 | 0.030 |
Why?
|
Antibodies | 1 | 2001 | 2425 | 0.030 |
Why?
|
Atherosclerosis | 1 | 2008 | 3431 | 0.030 |
Why?
|
Adolescent | 4 | 2016 | 89168 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 3816 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2017 | 1444 | 0.020 |
Why?
|
Counseling | 1 | 2019 | 1548 | 0.020 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2017 | 672 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2016 | 10784 | 0.020 |
Why?
|
Cardiomyopathies | 1 | 2004 | 2056 | 0.020 |
Why?
|
Injections, Intra-Arterial | 1 | 2011 | 181 | 0.020 |
Why?
|
Coronary Circulation | 1 | 2017 | 1617 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2019 | 4861 | 0.020 |
Why?
|
Exercise Test | 1 | 2019 | 2186 | 0.020 |
Why?
|
Trachea | 1 | 1997 | 1095 | 0.020 |
Why?
|
Cerebral Cortex | 1 | 2007 | 5827 | 0.020 |
Why?
|
Antioxidants | 1 | 1999 | 1678 | 0.020 |
Why?
|
Echocardiography | 2 | 2019 | 5043 | 0.020 |
Why?
|
Sex Factors | 1 | 2005 | 10647 | 0.020 |
Why?
|
Carbachol | 2 | 2004 | 223 | 0.020 |
Why?
|
Central Nervous System Stimulants | 1 | 2019 | 1180 | 0.020 |
Why?
|
Rats | 2 | 2011 | 23839 | 0.020 |
Why?
|
Acetanilides | 1 | 2011 | 169 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2001 | 8201 | 0.020 |
Why?
|
Risk Factors | 2 | 2019 | 74915 | 0.020 |
Why?
|
Escherichia coli Infections | 1 | 1993 | 524 | 0.020 |
Why?
|
Endocarditis, Bacterial | 1 | 1993 | 438 | 0.020 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2011 | 462 | 0.020 |
Why?
|
Postoperative Care | 1 | 2015 | 1481 | 0.020 |
Why?
|
Child, Preschool | 1 | 2011 | 42623 | 0.020 |
Why?
|
Knee Injuries | 1 | 2013 | 495 | 0.020 |
Why?
|
Hemodynamics | 2 | 2011 | 4202 | 0.020 |
Why?
|
Patient Care Team | 1 | 2019 | 2526 | 0.020 |
Why?
|
Capillaries | 1 | 2011 | 756 | 0.020 |
Why?
|
Genotype | 1 | 2022 | 13047 | 0.020 |
Why?
|
Oxidative Stress | 1 | 1999 | 3145 | 0.020 |
Why?
|
KATP Channels | 1 | 2007 | 49 | 0.020 |
Why?
|
Isoproterenol | 1 | 2007 | 398 | 0.020 |
Why?
|
Cytoprotection | 1 | 2007 | 201 | 0.020 |
Why?
|
Nitric Oxide | 2 | 2007 | 2146 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2020 | 18388 | 0.020 |
Why?
|
Neurosurgical Procedures | 1 | 2018 | 2097 | 0.020 |
Why?
|
Arthroscopy | 1 | 2013 | 971 | 0.020 |
Why?
|
Time Factors | 2 | 2019 | 40271 | 0.020 |
Why?
|
Preoperative Care | 1 | 2015 | 2257 | 0.020 |
Why?
|
Receptors, CXCR4 | 1 | 2011 | 729 | 0.020 |
Why?
|
Adrenergic beta-Agonists | 1 | 2007 | 347 | 0.020 |
Why?
|
Endocrine System Diseases | 1 | 1988 | 250 | 0.020 |
Why?
|
Sleep Bruxism | 1 | 2005 | 2 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39430 | 0.020 |
Why?
|
Receptors, Angiotensin | 1 | 2005 | 141 | 0.010 |
Why?
|
Logistic Models | 1 | 2019 | 13324 | 0.010 |
Why?
|
Caveolin 3 | 1 | 2004 | 24 | 0.010 |
Why?
|
Diagnosis, Differential | 2 | 2013 | 13026 | 0.010 |
Why?
|
Dystroglycans | 1 | 2004 | 62 | 0.010 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 1999 | 3440 | 0.010 |
Why?
|
Sarcoglycans | 1 | 2004 | 57 | 0.010 |
Why?
|
Mesocricetus | 1 | 2004 | 255 | 0.010 |
Why?
|
Young Adult | 3 | 2016 | 60045 | 0.010 |
Why?
|
Lymphoid Tissue | 1 | 2005 | 446 | 0.010 |
Why?
|
In Situ Nick-End Labeling | 1 | 2005 | 616 | 0.010 |
Why?
|
Caveolins | 1 | 2004 | 102 | 0.010 |
Why?
|
Calcium Channel Blockers | 1 | 2007 | 692 | 0.010 |
Why?
|
Muscular Dystrophy, Animal | 1 | 2004 | 89 | 0.010 |
Why?
|
Adrenergic Agonists | 1 | 2004 | 57 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 8051 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2005 | 11515 | 0.010 |
Why?
|
Atrial Natriuretic Factor | 1 | 2005 | 350 | 0.010 |
Why?
|
Retrospective Studies | 3 | 2019 | 81834 | 0.010 |
Why?
|
Neovascularization, Physiologic | 1 | 2011 | 1369 | 0.010 |
Why?
|
Microsomes | 1 | 2004 | 252 | 0.010 |
Why?
|
Nitric Oxide Synthase Type I | 1 | 2004 | 175 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2020 | 9263 | 0.010 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 2004 | 262 | 0.010 |
Why?
|
Brain Diseases | 1 | 1992 | 1553 | 0.010 |
Why?
|
Child | 1 | 2011 | 80863 | 0.010 |
Why?
|
Ileum | 1 | 2005 | 558 | 0.010 |
Why?
|
Multiple Organ Failure | 1 | 2005 | 387 | 0.010 |
Why?
|
Adrenal Glands | 1 | 2005 | 557 | 0.010 |
Why?
|
Prevalence | 1 | 2020 | 15880 | 0.010 |
Why?
|
Laminin | 1 | 2004 | 407 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7451 | 0.010 |
Why?
|
Gastric Mucosa | 1 | 2005 | 603 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2015 | 3586 | 0.010 |
Why?
|
Virulence Factors | 1 | 2005 | 512 | 0.010 |
Why?
|
Prospective Studies | 2 | 2017 | 54914 | 0.010 |
Why?
|
Restless Legs Syndrome | 1 | 2005 | 235 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 2004 | 1435 | 0.010 |
Why?
|
Research Design | 1 | 2017 | 6217 | 0.010 |
Why?
|
Biopsy | 1 | 2013 | 6816 | 0.010 |
Why?
|
Collagen Type I | 1 | 2005 | 620 | 0.010 |
Why?
|
Sarcomeres | 1 | 2004 | 378 | 0.010 |
Why?
|
Muscular Dystrophy, Duchenne | 1 | 2004 | 271 | 0.010 |
Why?
|
Mutation | 1 | 2006 | 30243 | 0.010 |
Why?
|
Mental Health | 1 | 2015 | 3271 | 0.010 |
Why?
|
Piperazines | 1 | 2011 | 2546 | 0.010 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2004 | 706 | 0.010 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 1993 | 2173 | 0.010 |
Why?
|
Cricetinae | 1 | 2004 | 2423 | 0.010 |
Why?
|
Cohort Studies | 1 | 2022 | 41797 | 0.010 |
Why?
|
Autoantibodies | 1 | 1988 | 2131 | 0.010 |
Why?
|
Malondialdehyde | 1 | 1999 | 113 | 0.010 |
Why?
|
Neuropeptides | 1 | 2004 | 950 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2019 | 26351 | 0.010 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2004 | 843 | 0.010 |
Why?
|
Opossums | 1 | 1997 | 104 | 0.010 |
Why?
|
Telomere | 1 | 2004 | 943 | 0.010 |
Why?
|
Benzylidene Compounds | 1 | 1997 | 25 | 0.010 |
Why?
|
Genistein | 1 | 1997 | 87 | 0.010 |
Why?
|
Muscle Relaxation | 1 | 1997 | 138 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2004 | 3790 | 0.010 |
Why?
|
Potassium Chloride | 1 | 1997 | 229 | 0.010 |
Why?
|
Acute Disease | 1 | 2007 | 7246 | 0.010 |
Why?
|
Collagen | 1 | 2005 | 2646 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2005 | 6241 | 0.010 |
Why?
|
Isoflavones | 1 | 1997 | 139 | 0.010 |
Why?
|
Glutathione | 1 | 1999 | 587 | 0.010 |
Why?
|
Protein Conformation | 1 | 2004 | 3973 | 0.010 |
Why?
|
Cyclic GMP | 1 | 1997 | 395 | 0.010 |
Why?
|
Autoimmune Diseases | 1 | 1988 | 2260 | 0.010 |
Why?
|
Stem Cell Transplantation | 1 | 2004 | 1602 | 0.010 |
Why?
|
Bone Marrow | 1 | 2005 | 2929 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2004 | 6242 | 0.010 |
Why?
|
Bone and Bones | 1 | 2005 | 2589 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 1999 | 12242 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2011 | 10358 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 2005 | 3048 | 0.010 |
Why?
|
Models, Molecular | 1 | 2004 | 5443 | 0.010 |
Why?
|
Survival Analysis | 1 | 2005 | 10125 | 0.010 |
Why?
|
Gene Expression | 1 | 2005 | 7605 | 0.010 |
Why?
|
Nitriles | 1 | 1997 | 984 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2005 | 11138 | 0.010 |
Why?
|
Cytokines | 1 | 2005 | 7449 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2013 | 20762 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2004 | 4984 | 0.000 |
Why?
|
Protein-Tyrosine Kinases | 1 | 1997 | 2434 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2013 | 59680 | 0.000 |
Why?
|
Case-Control Studies | 1 | 2005 | 22293 | 0.000 |
Why?
|
Enzyme Inhibitors | 1 | 1997 | 3734 | 0.000 |
Why?
|
Phosphorylation | 1 | 1997 | 8332 | 0.000 |
Why?
|
Genetic Predisposition to Disease | 1 | 2007 | 18048 | 0.000 |
Why?
|